Human Milk Oligosaccharides (HMO) Industry Research Report 2024
Summary
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to APO Research, the global Human Milk Oligosaccharides (HMO) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem and Dextra Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Milk Oligosaccharides (HMO).
The report will help the Human Milk Oligosaccharides (HMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Milk Oligosaccharides (HMO) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to APO Research, the global Human Milk Oligosaccharides (HMO) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem and Dextra Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Milk Oligosaccharides (HMO).
The report will help the Human Milk Oligosaccharides (HMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Abbott
- Inbiose
- Glycom
- Chr. Hansen (Jennewein)
- Elicityl SA
- ZuChem
- Dextra Laboratories
- 2'-FL & 3-FL
- Sialyllactose
- LNT & LNnT
- Infant Formula
- Functional Food & Beverages
- Food/Medical Supplements
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Milk Oligosaccharides (HMO) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Human Milk Oligosaccharides (HMO) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Human Milk Oligosaccharides (HMO) Sales (2019-2030)
2.2.3 Global Human Milk Oligosaccharides (HMO) Market Average Price (2019-2030)
2.3 Human Milk Oligosaccharides (HMO) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 2'-FL & 3-FL
2.3.3 Sialyllactose
2.3.4 LNT & LNnT
2.4 Human Milk Oligosaccharides (HMO) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Infant Formula
2.4.3 Functional Food & Beverages
2.4.4 Food/Medical Supplements
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Human Milk Oligosaccharides (HMO) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Human Milk Oligosaccharides (HMO) Sales (Tons) of Manufacturers (2019-2024)
3.3 Global Human Milk Oligosaccharides (HMO) Revenue of Manufacturers (2019-2024)
3.4 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturers (2019-2024)
3.5 Global Human Milk Oligosaccharides (HMO) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Human Milk Oligosaccharides (HMO), Product Type & Application
3.8 Global Manufacturers of Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
3.9 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Abbott
4.1.1 Abbott Company Information
4.1.2 Abbott Business Overview
4.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
4.1.5 Abbott Recent Developments
4.2 Inbiose
4.2.1 Inbiose Company Information
4.2.2 Inbiose Business Overview
4.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
4.2.5 Inbiose Recent Developments
4.3 Glycom
4.3.1 Glycom Company Information
4.3.2 Glycom Business Overview
4.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
4.3.5 Glycom Recent Developments
4.4 Chr. Hansen (Jennewein)
4.4.1 Chr. Hansen (Jennewein) Company Information
4.4.2 Chr. Hansen (Jennewein) Business Overview
4.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
4.4.5 Chr. Hansen (Jennewein) Recent Developments
4.5 Elicityl SA
4.5.1 Elicityl SA Company Information
4.5.2 Elicityl SA Business Overview
4.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
4.5.5 Elicityl SA Recent Developments
4.6 ZuChem
4.6.1 ZuChem Company Information
4.6.2 ZuChem Business Overview
4.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
4.6.5 ZuChem Recent Developments
4.7 Dextra Laboratories
4.7.1 Dextra Laboratories Company Information
4.7.2 Dextra Laboratories Business Overview
4.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
4.7.5 Dextra Laboratories Recent Developments
5 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SCENARIO BY REGION
5.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019-2030
5.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019-2024
5.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2025-2030
5.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019-2030
5.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019-2024
5.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2025-2030
5.4 North America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.4.1 North America Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.4.3 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.5.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.5.3 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.6.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.6.3 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.7.1 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.7.3 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.8.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
6.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030) & (Tons)
6.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
6.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
6.3 Global Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
7.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030) & (Tons)
7.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
7.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
7.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
7.3 Global Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
8.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Human Milk Oligosaccharides (HMO) Production Mode & Process
8.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Human Milk Oligosaccharides (HMO) Distributors
8.2.3 Human Milk Oligosaccharides (HMO) Customers
9 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) ANALYZING MARKET DYNAMICS
9.1 Human Milk Oligosaccharides (HMO) Industry Trends
9.2 Human Milk Oligosaccharides (HMO) Industry Drivers
9.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
9.4 Human Milk Oligosaccharides (HMO) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Human Milk Oligosaccharides (HMO) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Human Milk Oligosaccharides (HMO) Sales (2019-2030)
2.2.3 Global Human Milk Oligosaccharides (HMO) Market Average Price (2019-2030)
2.3 Human Milk Oligosaccharides (HMO) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 2'-FL & 3-FL
2.3.3 Sialyllactose
2.3.4 LNT & LNnT
2.4 Human Milk Oligosaccharides (HMO) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Infant Formula
2.4.3 Functional Food & Beverages
2.4.4 Food/Medical Supplements
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Human Milk Oligosaccharides (HMO) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Human Milk Oligosaccharides (HMO) Sales (Tons) of Manufacturers (2019-2024)
3.3 Global Human Milk Oligosaccharides (HMO) Revenue of Manufacturers (2019-2024)
3.4 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturers (2019-2024)
3.5 Global Human Milk Oligosaccharides (HMO) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Human Milk Oligosaccharides (HMO), Product Type & Application
3.8 Global Manufacturers of Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
3.9 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Abbott
4.1.1 Abbott Company Information
4.1.2 Abbott Business Overview
4.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
4.1.5 Abbott Recent Developments
4.2 Inbiose
4.2.1 Inbiose Company Information
4.2.2 Inbiose Business Overview
4.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
4.2.5 Inbiose Recent Developments
4.3 Glycom
4.3.1 Glycom Company Information
4.3.2 Glycom Business Overview
4.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
4.3.5 Glycom Recent Developments
4.4 Chr. Hansen (Jennewein)
4.4.1 Chr. Hansen (Jennewein) Company Information
4.4.2 Chr. Hansen (Jennewein) Business Overview
4.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
4.4.5 Chr. Hansen (Jennewein) Recent Developments
4.5 Elicityl SA
4.5.1 Elicityl SA Company Information
4.5.2 Elicityl SA Business Overview
4.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
4.5.5 Elicityl SA Recent Developments
4.6 ZuChem
4.6.1 ZuChem Company Information
4.6.2 ZuChem Business Overview
4.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
4.6.5 ZuChem Recent Developments
4.7 Dextra Laboratories
4.7.1 Dextra Laboratories Company Information
4.7.2 Dextra Laboratories Business Overview
4.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
4.7.5 Dextra Laboratories Recent Developments
5 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SCENARIO BY REGION
5.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019-2030
5.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019-2024
5.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2025-2030
5.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019-2030
5.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019-2024
5.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2025-2030
5.4 North America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.4.1 North America Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.4.3 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.5.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.5.3 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.6.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.6.3 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.7.1 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.7.3 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
5.8.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
6.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030) & (Tons)
6.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
6.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
6.3 Global Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
7.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030) & (Tons)
7.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
7.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
7.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
7.3 Global Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
8.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Human Milk Oligosaccharides (HMO) Production Mode & Process
8.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Human Milk Oligosaccharides (HMO) Distributors
8.2.3 Human Milk Oligosaccharides (HMO) Customers
9 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) ANALYZING MARKET DYNAMICS
9.1 Human Milk Oligosaccharides (HMO) Industry Trends
9.2 Human Milk Oligosaccharides (HMO) Industry Drivers
9.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
9.4 Human Milk Oligosaccharides (HMO) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Human Milk Oligosaccharides (HMO) Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Human Milk Oligosaccharides (HMO) Sales (Tons) of Manufacturers (2018-2023)
Table 7. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Human Milk Oligosaccharides (HMO) Revenue of Manufacturers (2018-2023)
Table 9. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) of Manufacturers (2018-2023)
Table 11. Global Human Milk Oligosaccharides (HMO) Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Human Milk Oligosaccharides (HMO), Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Abbott Company Information
Table 17. Abbott Business Overview
Table 18. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 19. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
Table 20. Abbott Recent Developments
Table 21. Inbiose Company Information
Table 22. Inbiose Business Overview
Table 23. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 24. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
Table 25. Inbiose Recent Developments
Table 26. Glycom Company Information
Table 27. Glycom Business Overview
Table 28. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 29. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
Table 30. Glycom Recent Developments
Table 31. Chr. Hansen (Jennewein) Company Information
Table 32. Chr. Hansen (Jennewein) Business Overview
Table 33. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 34. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
Table 35. Chr. Hansen (Jennewein) Recent Developments
Table 36. Elicityl SA Company Information
Table 37. Elicityl SA Business Overview
Table 38. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 39. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
Table 40. Elicityl SA Recent Developments
Table 41. ZuChem Company Information
Table 42. ZuChem Business Overview
Table 43. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 44. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
Table 45. ZuChem Recent Developments
Table 46. Dextra Laboratories Company Information
Table 47. Dextra Laboratories Business Overview
Table 48. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 49. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
Table 50. Dextra Laboratories Recent Developments
Table 51. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 52. Global Human Milk Oligosaccharides (HMO) Sales by Region (2018-2023) & (Tons)
Table 53. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2018-2023)
Table 54. Global Human Milk Oligosaccharides (HMO) Sales by Region (2024-2029) & (Tons)
Table 55. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2024-2029)
Table 56. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2018-2023) & (US$ Million)
Table 57. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2018-2023)
Table 58. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2024-2029) & (US$ Million)
Table 59. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2024-2029)
Table 60. North America Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. North America Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 62. North America Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 63. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 64. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 65. Europe Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 67. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 68. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 69. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 70. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 72. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 73. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 74. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 75. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 77. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 78. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 79. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 80. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 82. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 83. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 84. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 85. Global Human Milk Oligosaccharides (HMO) Sales by Type (2018-2023) & (Tons)
Table 86. Global Human Milk Oligosaccharides (HMO) Sales by Type (2024-2029) & (Tons)
Table 87. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2018-2023)
Table 88. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2024-2029)
Table 89. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2018-2023) & (US$ Million)
Table 90. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2024-2029) & (US$ Million)
Table 91. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2018-2023)
Table 92. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2024-2029)
Table 93. Global Human Milk Oligosaccharides (HMO) Price by Type (2018-2023) & (USD/Ton)
Table 94. Global Human Milk Oligosaccharides (HMO) Price by Type (2024-2029) & (USD/Ton)
Table 95. Global Human Milk Oligosaccharides (HMO) Sales by Application (2018-2023) & (Tons)
Table 96. Global Human Milk Oligosaccharides (HMO) Sales by Application (2024-2029) & (Tons)
Table 97. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2018-2023)
Table 98. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2024-2029)
Table 99. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2018-2023) & (US$ Million)
Table 100. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2024-2029) & (US$ Million)
Table 101. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2018-2023)
Table 102. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2024-2029)
Table 103. Global Human Milk Oligosaccharides (HMO) Price by Application (2018-2023) & (USD/Ton)
Table 104. Global Human Milk Oligosaccharides (HMO) Price by Application (2024-2029) & (USD/Ton)
Table 105. Key Raw Materials
Table 106. Raw Materials Key Suppliers
Table 107. Human Milk Oligosaccharides (HMO) Distributors List
Table 108. Human Milk Oligosaccharides (HMO) Customers List
Table 109. Human Milk Oligosaccharides (HMO) Industry Trends
Table 110. Human Milk Oligosaccharides (HMO) Industry Drivers
Table 111. Human Milk Oligosaccharides (HMO) Industry Restraints
Table 112. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Human Milk Oligosaccharides (HMO) Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Human Milk Oligosaccharides (HMO) Sales (Tons) of Manufacturers (2018-2023)
Table 7. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Human Milk Oligosaccharides (HMO) Revenue of Manufacturers (2018-2023)
Table 9. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) of Manufacturers (2018-2023)
Table 11. Global Human Milk Oligosaccharides (HMO) Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Human Milk Oligosaccharides (HMO), Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Abbott Company Information
Table 17. Abbott Business Overview
Table 18. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 19. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
Table 20. Abbott Recent Developments
Table 21. Inbiose Company Information
Table 22. Inbiose Business Overview
Table 23. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 24. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
Table 25. Inbiose Recent Developments
Table 26. Glycom Company Information
Table 27. Glycom Business Overview
Table 28. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 29. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
Table 30. Glycom Recent Developments
Table 31. Chr. Hansen (Jennewein) Company Information
Table 32. Chr. Hansen (Jennewein) Business Overview
Table 33. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 34. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
Table 35. Chr. Hansen (Jennewein) Recent Developments
Table 36. Elicityl SA Company Information
Table 37. Elicityl SA Business Overview
Table 38. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 39. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
Table 40. Elicityl SA Recent Developments
Table 41. ZuChem Company Information
Table 42. ZuChem Business Overview
Table 43. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 44. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
Table 45. ZuChem Recent Developments
Table 46. Dextra Laboratories Company Information
Table 47. Dextra Laboratories Business Overview
Table 48. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 49. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
Table 50. Dextra Laboratories Recent Developments
Table 51. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 52. Global Human Milk Oligosaccharides (HMO) Sales by Region (2018-2023) & (Tons)
Table 53. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2018-2023)
Table 54. Global Human Milk Oligosaccharides (HMO) Sales by Region (2024-2029) & (Tons)
Table 55. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2024-2029)
Table 56. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2018-2023) & (US$ Million)
Table 57. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2018-2023)
Table 58. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2024-2029) & (US$ Million)
Table 59. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2024-2029)
Table 60. North America Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. North America Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 62. North America Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 63. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 64. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 65. Europe Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 67. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 68. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 69. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 70. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 72. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 73. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 74. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 75. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 77. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 78. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 79. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 80. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2018-2023) & (Tons)
Table 82. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2024-2029) & (Tons)
Table 83. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2018-2023) & (US$ Million)
Table 84. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2024-2029) & (US$ Million)
Table 85. Global Human Milk Oligosaccharides (HMO) Sales by Type (2018-2023) & (Tons)
Table 86. Global Human Milk Oligosaccharides (HMO) Sales by Type (2024-2029) & (Tons)
Table 87. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2018-2023)
Table 88. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2024-2029)
Table 89. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2018-2023) & (US$ Million)
Table 90. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2024-2029) & (US$ Million)
Table 91. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2018-2023)
Table 92. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2024-2029)
Table 93. Global Human Milk Oligosaccharides (HMO) Price by Type (2018-2023) & (USD/Ton)
Table 94. Global Human Milk Oligosaccharides (HMO) Price by Type (2024-2029) & (USD/Ton)
Table 95. Global Human Milk Oligosaccharides (HMO) Sales by Application (2018-2023) & (Tons)
Table 96. Global Human Milk Oligosaccharides (HMO) Sales by Application (2024-2029) & (Tons)
Table 97. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2018-2023)
Table 98. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2024-2029)
Table 99. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2018-2023) & (US$ Million)
Table 100. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2024-2029) & (US$ Million)
Table 101. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2018-2023)
Table 102. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2024-2029)
Table 103. Global Human Milk Oligosaccharides (HMO) Price by Application (2018-2023) & (USD/Ton)
Table 104. Global Human Milk Oligosaccharides (HMO) Price by Application (2024-2029) & (USD/Ton)
Table 105. Key Raw Materials
Table 106. Raw Materials Key Suppliers
Table 107. Human Milk Oligosaccharides (HMO) Distributors List
Table 108. Human Milk Oligosaccharides (HMO) Customers List
Table 109. Human Milk Oligosaccharides (HMO) Industry Trends
Table 110. Human Milk Oligosaccharides (HMO) Industry Drivers
Table 111. Human Milk Oligosaccharides (HMO) Industry Restraints
Table 112. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Human Milk Oligosaccharides (HMO)Product Picture
Figure 5. Global Human Milk Oligosaccharides (HMO) Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Human Milk Oligosaccharides (HMO) Market Size (2018-2029) & (US$ Million)
Figure 7. Global Human Milk Oligosaccharides (HMO) Sales (2018-2029) & (Tons)
Figure 8. Global Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) & (2018-2029)
Figure 9. 2'-FL & 3-FL Product Picture
Figure 10. Sialyllactose Product Picture
Figure 11. LNT & LNnT Product Picture
Figure 12. Infant Formula Product Picture
Figure 13. Functional Food & Beverages Product Picture
Figure 14. Food/Medical Supplements Product Picture
Figure 15. Others Product Picture
Figure 16. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Human Milk Oligosaccharides (HMO) Sales by Region in 2022
Figure 23. Global Human Milk Oligosaccharides (HMO) Revenue by Region in 2022
Figure 24. North America Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 25. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 26. North America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 30. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 31. Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 32. Germany Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 38. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 40. China Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 50. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 51. Latin America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 56. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2018-2029)
Figure 62. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2018-2029)
Figure 63. Global Human Milk Oligosaccharides (HMO) Price (USD/Ton) by Type (2018-2029)
Figure 64. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2018-2029)
Figure 65. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2018-2029)
Figure 66. Global Human Milk Oligosaccharides (HMO) Price (USD/Ton) by Application (2018-2029)
Figure 67. Human Milk Oligosaccharides (HMO) Value Chain
Figure 68. Human Milk Oligosaccharides (HMO) Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Human Milk Oligosaccharides (HMO)Product Picture
Figure 5. Global Human Milk Oligosaccharides (HMO) Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Human Milk Oligosaccharides (HMO) Market Size (2018-2029) & (US$ Million)
Figure 7. Global Human Milk Oligosaccharides (HMO) Sales (2018-2029) & (Tons)
Figure 8. Global Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) & (2018-2029)
Figure 9. 2'-FL & 3-FL Product Picture
Figure 10. Sialyllactose Product Picture
Figure 11. LNT & LNnT Product Picture
Figure 12. Infant Formula Product Picture
Figure 13. Functional Food & Beverages Product Picture
Figure 14. Food/Medical Supplements Product Picture
Figure 15. Others Product Picture
Figure 16. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Human Milk Oligosaccharides (HMO) Sales by Region in 2022
Figure 23. Global Human Milk Oligosaccharides (HMO) Revenue by Region in 2022
Figure 24. North America Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 25. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 26. North America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 30. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 31. Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 32. Germany Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 38. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 40. China Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 50. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 51. Latin America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country in 2022
Figure 56. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2018-2029)
Figure 62. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2018-2029)
Figure 63. Global Human Milk Oligosaccharides (HMO) Price (USD/Ton) by Type (2018-2029)
Figure 64. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2018-2029)
Figure 65. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2018-2029)
Figure 66. Global Human Milk Oligosaccharides (HMO) Price (USD/Ton) by Application (2018-2029)
Figure 67. Human Milk Oligosaccharides (HMO) Value Chain
Figure 68. Human Milk Oligosaccharides (HMO) Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
